| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |